DENDRITICS
 
 
News
03/02/2010  Sponsoring of a meeting in London

Regulatory T cells in inflammatory and infectious diseases: new horizons of old friends.

At London 5thMarch 2010

01/12/2009  Recent Methods in Dendritic Cell Research

Dendritic Cell Protocols, Second Edition. Naik, Shalin H.(Ed.)
 

News

13/2/2009  
Advances in Toll-like Receptor research

Barton G.M. et al., Nat Rev Immunol, 2009, 9, 535- A cell biological view of Toll-like receptor function regulation through compartmentalization.

Ewald S.E. et al., Nature Letters 2008, 456, 658Park B. et al.,Nature Immunol, 2008, 9, 1407-

Dendritics offers TLR3 antibodies for functional receptor studies

 

 



 

    human basophil

DENDRITICS offers a wide range of monoclonal antibodies to characterize dendritic cell phenotype and function, in the steady-state, in animal models and in human diseases such as allergy, cancer, and skin diseases.

DENDRITICS offers a specific monoclonal antibody custom-made service: you are garanteed to get several clones (10-40)  for your specific program.

DENDRITICS antibodies can be used in   Flow cytometry, ELISA, Immunohistology, and biochemical studies.

DENDRITICS created in 2005, leans on:

  • 15 years of expertise in dendritic cells and immunology fundamental research and iacquired within the Laboratory of Immunological Research of Schering-Plough, LIR (200 publications and 40 patents).
  • The exclusive license of Schering-Plough to manufacture and to sell LIR antibodies as DCGM4-Langerin, clone 120G8 for mouse pDCs depletion, DC-LAMP, DCIR, antibasophil, FDF03..
  • The most of Dendritics monoclonal antibodies have been published and validated in major international journals.

 

 

DENDRITICS monoclonal antibodies do not contain sodium azide or other preservatives.